Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
6.94
-0.10 (-1.42%)
Mar 24, 2026, 4:00 PM EDT - Market closed
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $672.93 million as of March 24, 2026. Its market cap has decreased by -24.10% in one year.
Market Cap
672.93M
Enterprise Value
621.44M
1-Year Change
-24.10%
Ranking
Category
Stock Price
$6.94
Market Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $672.93M, an increase of 30.56%. That is a compound annual growth rate of 11.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 633.72M | -1.24% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kura Oncology | 712.82M |
| MannKind | 705.55M |
| Bright Minds Biosciences | 703.37M |
| BridgeBio Oncology Therapeutics | 697.89M |
| Arvinas | 658.16M |
| Solid Biosciences | 657.25M |
| Jade Biosciences | 653.93M |
| Alto Neuroscience | 644.98M |